Literature DB >> 15654837

Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.

Y Imamura1, M S Kurokawa, H Yoshikawa, K Nara, E Takada, C Masuda, S Tsukikawa, S Ozaki, T Matsuda, N Suzuki.   

Abstract

Involvement of excessive Th1 cell functions and heat shock protein expression in the pathogenesis of Behcet's disease (BD) has been reported. In this study we have characterized immune responses in intestinal lesions of BD. Peripheral blood lymphocytes (PBL) of BD and healthy controls (HC) and tissue specimens of intestinal Behcet's disease (intestinal BD), Crohn's disease (CD) and ulcerative colitis (UC) were analysed for mRNA and protein expression by reverse transcriptase-polymerase chain reaction (PCR) and immunohistochemistry, respectively. PBL of BD patients expressed the Th1-related chemokine receptor, CCR5 and CXCR3 preferentially compared with those of healthy controls. Intestinal lesions of BD expressed interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha and interleukin (IL)-12 mRNA, indicating Th1 skewed responses in vivo. mRNA of Txk, a Tec family tyrosine kinase specific to Th1 cells, was expressed in the lesions, suggesting its contribution to the Th1-dominant responses. In the intestinal samples, CCR5 was detected in all the cases with BD, whereas Th2-related CCR3 and CCR4 were detected randomly, mainly in the cases with inactive BD and those receiving large amounts of prednisolone, indicating the Th1-dominant immune responses in the intestinal lesions. As the ligands of CCR5, MIP1alpha and MIP1beta were detected, whereas RANTES was not. Heat shock protein (HSP) 60 was expressed in PBL and intestinal tissues of BD. Th1-dominant immune responses and HSP60 expression may induce the inflammatory responses and thus be associated with the pathogenesis of intestinal BD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654837      PMCID: PMC1809277          DOI: 10.1111/j.1365-2249.2005.02695.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  IL-8 producing cells in patients with Behçet's disease.

Authors:  C Mantas; H Direskeneli; D Oz; S Yavuz; T Akoglu
Journal:  Clin Exp Rheumatol       Date:  2000 Mar-Apr       Impact factor: 4.473

Review 2.  Immunopathogenesis of Behçet's disease.

Authors:  T Lehner
Journal:  Ann Med Interne (Paris)       Date:  1999-10

3.  Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report.

Authors:  P V Hassard; S W Binder; V Nelson; E A Vasiliauskas
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

4.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Authors:  H Direskeneli; E Ekşioglu-Demiralp; S Yavuz; T Ergun; T Shinnick; T Lehner; T Akoglu
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

6.  Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.

Authors:  R M Vabulas; P Ahmad-Nejad; C da Costa; T Miethke; C J Kirschning; H Häcker; H Wagner
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

7.  H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells.

Authors:  Y Tanaka; Y Minami; S Mine; H Hirano; C D Hu; H Fujimoto; K Fujii; K Saito; J Tsukada; Y van Kooyk; C G Figdor; T Kataoka; S Eto
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

8.  Histopathologic features of erythema nodosum--like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis.

Authors:  B Kim; P E LeBoit
Journal:  Am J Dermatopathol       Date:  2000-10       Impact factor: 1.533

9.  Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease.

Authors:  P Mariani; A Bachetoni; M D'Alessandro; D Lomanto; P Mazzocchi; V Speranza
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

10.  Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes.

Authors:  J Kashiwakura; N Suzuki; H Nagafuchi; M Takeno; Y Takeba; Y Shimoyama; T Sakane
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  42 in total

1.  Hsp60 and Hsp10 increase in colon mucosa of Crohn’s disease and ulcerative colitis.

Authors:  Vito Rodolico; Giovanni Tomasello; Monica Zerilli; Anna Martorana; Alessandro Pitruzzella; Antonella Marino Gammazza; Sabrina David; Giovanni Zummo; Provvidenza Damiani; Salvatore Accomando; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2010-11       Impact factor: 3.667

2.  Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

Authors:  K Nara; M S Kurokawa; S Chiba; H Yoshikawa; S Tsukikawa; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 3.  HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind.

Authors:  Jean-Eric Alard; Maryvonne Dueymes; Pierre Youinou; Christophe Jamin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Serum omentin, resistin and tumour necrosis factor-α levels in Behcet patients with and without ocular involvement.

Authors:  Fatih Mehmet Türkcü; Alparslan Şahin; Abdullah Kürşat Cingü; Savaş Kaya; Hatice Yüksel; Yasin Cinar; İbrahim Batmaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-23       Impact factor: 3.117

5.  Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease.

Authors:  Moriaki Hatsugai; Manae S Kurokawa; Takefumi Kouro; Kohei Nagai; Mitsumi Arito; Kayo Masuko; Naoya Suematsu; Kazuki Okamoto; Fumio Itoh; Tomohiro Kato
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

6.  Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Authors:  Jun Shimizu; Kenji Takai; Erika Takada; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2015-05-14       Impact factor: 2.980

Review 7.  Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.

Authors:  Noboru Suzuki; Kazuhiko Nara; Tomoko Suzuki
Journal:  Clin Med Res       Date:  2006-06

8.  Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

Authors:  J Shimizu; K Takai; N Fujiwara; N Arimitsu; Y Ueda; S Wakisaka; H Yoshikawa; F Kaneko; T Suzuki; N Suzuki
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 9.  Chronic infections and atherosclerosis.

Authors:  Kiyoshi Ayada; Kenji Yokota; Kazuko Kobayashi; Yehuda Shoenfeld; Eiji Matsuura; Keiji Oguma
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

10.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.